SCHEMBL7320774

SCHEMBL7320774

CCC(NC(=O)c1cccc(NS(=O)(=O)c2ccc3ccccc3c2)c1)N1CCN(C(CC)NC(=O)c2cccc(NS(=O)(=O)c3ccc4ccccc4c3)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.51
HTR1A P08908 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
HTR7 P34969 1/20 0.51
DRD3 P35462 1/20 0.51
HTR6 P50406 1/20 0.51
LMNA P02545 3/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
AR P10275 1/20 0.47
KAT6A Q92794 5/20 0.47
PLAU P00749 2/20 0.47
GPR27 Q9NS67 1/20 0.47
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
GHSR Q92847 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7787817 0.84 AKR1C3 (0.53) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7787806 0.83 AKR1C3 (0.52) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7790027 0.80 AKR1C3 (0.51) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7790030 0.80 AKR1C3 (0.51) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7782228 0.79 AKR1C3 (0.50) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7782230 0.79 AKR1C3 (0.50) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7320733 0.76 DRD3 (0.61) HTR7DRD3
SCHEMBL7791333 0.76 AKR1C3 (0.54) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7791335 0.76 AKR1C3 (0.54) AKR1C3LMNAALDH1A1GAASMN1; SMN2
SCHEMBL7786983 0.76 AKR1C3 (0.48) AKR1C3LMNAALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5612378-A TREATING THROMBOSIS, ISCHEMIA, STROKE, RESTENOSIS OR INFLAMMATION 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1997-03-18 US disclosed
WO-1996039380-A1 BIS-ARYLSULFONYLAMINOBENZAMIDE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1996-12-12 WO disclosed